Your institution may have access to this item. Find your institution then sign in to continue.
Title
ASO Author Reflections: Selecting Patients for Elimination of Surgery Trials—Predicting Residual Invasive and In Situ Disease in Patients with HER2-Positive Breast Cancer After Neoadjuvant Systemic Therapy.